Literature DB >> 22778873

Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces.

Elizabeth A Yates1, Elena M Cucco, Justin Legleiter.   

Abstract

A pathological hallmark of Alzheimer's disease (AD), a late onset neurodegenerative disease, is the development of neuritic amyloid plaques, composed predominantly of aggregates of the β-amyloid (Aβ) peptide. It has been demonstrated that Aβ can aggregate into a variety of polymorphic aggregate structures under different chemical environments, and a potentially important environmental factor in dictating aggregate structure is the presence of surfaces. There are also several mutations clustered around the central hydrophobic core of Aβ (E22G Arctic mutation, E22K Italian mutation, D23N Iowa mutation, and A21G Flemish mutation). These mutations are associated with hereditary diseases ranging from almost pure cerebral amyloid angiopathy (CAA) to typical Alzheimer's disease pathology. The goal of this study was to determine how these mutations influence the morphology of Aβ aggregates under free solution conditions and at an anionic surface/liquid interface. While the rate of formation of specific aggregates was altered by mutations in Aβ under free solution conditions, the respective aggregate morphologies were similar. However, aggregation occurring directly on a negatively charged mica surface resulted in distinct aggregate morphologies formed by different mutant forms of Aβ. These studies provide insight into the potential role anionic surfaces play in dictating the formation of Aβ polymorphic aggregate structures.

Entities:  

Keywords:  Alzheimer’s disease; Atomic force microscopy; point mutations in Aβ; polymorphic aggregate formation; protein aggregation; β-amyloid

Mesh:

Substances:

Year:  2011        PMID: 22778873      PMCID: PMC3369758          DOI: 10.1021/cn200001k

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  49 in total

1.  Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

Authors:  L Miravalle; T Tokuda; R Chiarle; G Giaccone; O Bugiani; F Tagliavini; B Frangione; J Ghiso
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

2.  In-situ atomic force microscopy study of beta-amyloid fibrillization.

Authors:  H K Blackley; G H Sanders; M C Davies; C J Roberts; S J Tendler; M J Wilkinson
Journal:  J Mol Biol       Date:  2000-05-19       Impact factor: 5.469

3.  Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins.

Authors:  G Bitan; A Lomakin; D B Teplow
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

4.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

Authors:  C Nilsberth; A Westlind-Danielsson; C B Eckman; M M Condron; K Axelman; C Forsell; C Stenh; J Luthman; D B Teplow; S G Younkin; J Näslund; L Lannfelt
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

5.  Pathogenic effects of D23N Iowa mutant amyloid beta -protein.

Authors:  W E Van Nostrand; J P Melchor; H S Cho; S M Greenberg; G W Rebeck
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

Review 6.  Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease.

Authors:  M M Verbeek; P Eikelenboom; R M de Waal
Journal:  J Neuropathol Exp Neurol       Date:  1997-07       Impact factor: 3.685

7.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

8.  Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides.

Authors:  N Demeester; C Mertens; H Caster; M Goethals; J Vandekerckhove; M Rosseneu; C Labeur
Journal:  Eur J Neurosci       Date:  2001-06       Impact factor: 3.386

9.  Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types.

Authors:  A K Sian; E R Frears; O M El-Agnaf; B P Patel; M F Manca; G Siligardi; R Hussain; B M Austen
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

10.  The Arctic Alzheimer mutation enhances sensitivity to toxic stress in human neuroblastoma cells.

Authors:  Kristina Sennvik; Camilla Nilsberth; Charlotte Stenh; Lars Lannfelt; Eirikur Benedikz
Journal:  Neurosci Lett       Date:  2002-06-21       Impact factor: 3.046

View more
  7 in total

1.  The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

Authors:  Justin Legleiter; John D Fryer; David M Holtzman; Andtomasz Kowalewski
Journal:  ACS Chem Neurosci       Date:  2011-10-19       Impact factor: 4.418

Review 2.  Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.

Authors:  Adewale Adegbuyiro; Faezeh Sedighi; Albert W Pilkington; Sharon Groover; Justin Legleiter
Journal:  Biochemistry       Date:  2017-02-21       Impact factor: 3.162

3.  Cholesterol Modifies Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.

Authors:  Xiang Gao; Warren A Campbell; Maxmore Chaibva; Pranav Jain; Ashley E Leslie; Shelli L Frey; Justin Legleiter
Journal:  Biochemistry       Date:  2015-12-22       Impact factor: 3.162

Review 4.  The role of amyloidogenic protein oligomerization in neurodegenerative disease.

Authors:  Gregor P Lotz; Justin Legleiter
Journal:  J Mol Med (Berl)       Date:  2013-03-27       Impact factor: 4.599

5.  Acetylation of Aβ40 Alters Aggregation in the Presence and Absence of Lipid Membranes.

Authors:  Albert W Pilkington; Jane Schupp; Morgan Nyman; Stephen J Valentine; David M Smith; Justin Legleiter
Journal:  ACS Chem Neurosci       Date:  2019-12-27       Impact factor: 4.418

6.  Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.

Authors:  Kathleen A Burke; Elizabeth A Yates; Justin Legleiter
Journal:  Front Neurol       Date:  2013-03-01       Impact factor: 4.003

7.  Macromolecular crowding in solution alters huntingtin interaction and aggregation at interfaces.

Authors:  Sharon E Groover; Adewale Adegbuyiro; Caleb K Fan; Breanna L Hodges; Maryssa Beasley; Katelyn Taylor; Alyssa R Stonebraker; Chathuranga Siriwardhana; Justin Legleiter
Journal:  Colloids Surf B Biointerfaces       Date:  2021-07-07       Impact factor: 5.999

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.